Biomarin Pharmaceutical Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$776,133	$825,410	$745,145	$747,313
Gross Profit	636,048	675,320	593,587	611,174
EBITDA	-5,258	319,110	263,021	195,496
EBIT	-23,745	300,547	240,952	171,889
Net Income	-30,744	240,532	185,686	124,943
Net Change In Cash	776,133	825,410	745,145	747,313
Free Cash Flow	340,238	168,170	157,626	165,328
Cash	1,250,108	1,213,816	1,048,803	942,842
Basic Shares	192,032	196,643	196,474	196,581

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,853,915	$2,419,226	$2,096,039	$1,846,275
Gross Profit	2,273,680	1,887,164	1,593,016	1,375,760
EBITDA	650,528	306,773	265,359	47,433
EBIT	554,102	202,387	163,390	-60,606
Net Income	426,859	167,645	141,561	-64,080
Net Change In Cash	2,853,915	2,419,226	2,096,039	1,846,275
Cost of Revenue				-61,882
Free Cash Flow	475,423	62,568	54,943	185,311
Cash	942,842	755,127	724,531	587,276
Basic Shares	196,708	191,595	188,963	182,852